MUFG Americas’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

MUFG Americas’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-516	Closed	-$4K	–	1240
2017 Q2	$4K	Hold	516	–	–	﹤0.01%	964
2017 Q1	$3K	Hold	516	–	–	﹤0.01%	1013
2016 Q4	$2K	Sell	516 -536	-51%	-$2.25K	﹤0.01%	1041
2016 Q3	$5K	Sell	1,052 -1,518	-59%	-$8.99K	﹤0.01%	984
2016 Q2	$17K	Hold	2,570	–	–	﹤0.01%	741
2016 Q1	$16K	Sell	2,570 -1,720	-40%	-$8.82K	﹤0.01%	747
2015 Q4	$26K	Hold	4,290	–	–	﹤0.01%	669
2015 Q3	$26K	Buy	4,290 +450	+12%	+$3.12K	﹤0.01%	692
2015 Q2	$26K	Sell	3,840 -5,650	-60%	-$35.9K	﹤0.01%	716
2015 Q1	$58K	Buy	9,490 +1,910	+25%	+$12.7K	﹤0.01%	641
2014 Q4	$53K	Buy	7,580 +2,860	+61%	+$21K	﹤0.01%	661
2014 Q3	$38K	Buy	+4,720	New	+$36.9K	﹤0.01%	721

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MUFG Americas's SPPI Position: Q3 2017 in Review

MUFG Americas sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2017, closing a stake of 516 shares — an estimated $4K sold.

MUFG Americas first reported a position in SPPI in Q3 2014 and held it in 12 quarters. The position peaked at $58K in Q1 2015. 158 funds tracked by Wall St. Rank hold SPPI as of Q3 2017.

MUFG Americas reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2017 after selling out during the quarter.
MUFG Americas sold 516 Spectrum Pharmaceuticals Inc shares in Q3 2017, an estimated $4K.
MUFG Americas first reported a position in Spectrum Pharmaceuticals Inc in Q3 2014 and held it in 12 quarters.
MUFG Americas's Spectrum Pharmaceuticals Inc position peaked at $58K in Q1 2015.
158 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2017.

Based on MUFG Americas's 13F filing for Q3 2017, filed 13 Nov 2017.